Medical Ventures Corp., a medical devices company specializing in products for the cardiovascular and surgical markets, announced today it has received European CE Mark approval for its Metricath Gemini balloon-catheter product. The device is used during angioplasty procedures to measure and treat damaged blood vessels in patients suffering from cardiovascular disease. The approval allows the company to market and sell the product in the European Union, where over 800,000 people undergo angioplasties each year.

Medical Ventures (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=602954)